(Q77583415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

meta-analysis

0 references

title

Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

Philip Jong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Catherine Demers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Robert S McKelvie

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Peter P Liu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

463-470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Angiotensin receptor blockers for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Clinical safety and tolerability of losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Valsartan in heart failure patients previously untreated with an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Overcoming the limitations of current meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

Bias in the one-step method for pooling study results.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901775-2

7 January 2021

10.1016/S0735-1097(01)01775-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11823085%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference